Loading clinical trials...

Endocrine Determinants of Renal Function in Patients With Hypoparathyroidism | Clinical Trials | Clareo Health

COMPLETED

Endocrine Determinants of Renal Function in Patients With Hypoparathyroidism

Endocrine Determinants of Renal Function in Patients With Hypoparathyroidism on Conventional Treatment: a Cross-sectional Study

NCT06449729•IRCCS San Raffaele

View on ClinicalTrials.gov

Summary

Endocrine determinants of renal function in patients with hypoparathyroidism on conventional treatment: a cross-sectional study (ENDORSE)

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•age ≥ 18 years
•diagnosis of chronic (≥ 1 year) post-surgical and autoimmune hypoparathyroidism, as established with undetectable or insufficient PTH concentration in relation to the presence of hypocalcemia
•patients being treated with calcitriol or alfacalcidiol
•patients able to sign the written informed consent

Exclusion Criteria

•pregnancy
•severe renal failure requiring dialysis treatment
•macroproteinuria
•use of antihypertensive drugs such as thiazides, ACE inhibitors, sartans, beta and alpha blockers, and antialdosterone drugs
•pazients affected by diabetes mellitus- insulin-treated

Locations (1)

Andrea Giustina

Milan, Italy

Key Dates

Start Date

November 28, 2022

Primary Completion Date

April 28, 2023

Completion Date

April 28, 2023

Last Updated

June 10, 2024

Enrollment

ACTUAL participants

Conditions

Hypoparathyroidism

Interventions

Blood sample and urine collection

DIAGNOSTIC_TEST

A Global Pregnancy Registry to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to YORVIPATH® (Palopegteriparatide) During Pregnancy and Breastfeeding

NCT07345494

Hypoparathyroidism

View study

RECRUITINGPHASE1/PHASE2

Parathyroid Allotransplant for Treatment of Hypoparathyroidism

NCT06961071

HypoparathyroidismHypoparathyroidism Postprocedural+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 10, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Endocrine Determinants of Renal Function in Patients With Hypoparathyroidism

Inclusion Criteria

Exclusion Criteria

A Global Pregnancy Registry to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to YORVIPATH® (Palopegteriparatide) During Pregnancy and Breastfeeding

Parathyroid Allotransplant for Treatment of Hypoparathyroidism

Hypoparathyroidism Natural History Study

Efficacy and Safety of XH02 for the Treatment of Hypoparathyroidism

PTeye vs Surgeons Eyes in Intraoperative Identification and Functional Preservation of Parathyroid Glands During Thyroid Surgery: A Parallel Randomized Controlled Clinical Trial.

Parathyroid Allotransplant for Severe Refractory Hypoparathyroidism